StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3036% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals SBC capitalized into inventory by Year

SBC capitalized into inventory ($M) ($M)

Vertex Pharmaceuticals SBC capitalized into inventory: $14.4M in FY2025, up 35.8% from a year earlier. That is the highest of the 11 years on record here.

Latest, FY2025
14.4
Period ended Dec 31, 2025
Change on a year earlier
+35.8%
10.6 in FY2024
History
11 years
Since FY2015
Sources
9
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-13) ↗

Reported in Form 10-Q / 10-K Note (Stock-based Compensation).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedSBC capitalized into inventory ($M) ($M)Year on yearSource
FY2025Dec 31, 202514.4+35.8%Form 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 202410.6+360.9%Form 10-K (filed 2026-02-13) ↗
FY2023Dec 31, 20232.30-355.6%Form 10-K (filed 2026-02-13) ↗
FY2022Dec 31, 2022-0.90-122.0%Form 10-K (filed 2025-02-13) ↗
FY2021Dec 31, 20214.10+13.9%Form 10-K (filed 2024-02-15) ↗
FY2020Dec 31, 20203.60+111.8%Form 10-K (filed 2023-02-10) ↗
FY2019Dec 31, 20191.70+183.3%Form 10-K (filed 2022-02-09) ↗
FY2018Dec 31, 20180.60-75.0%Form 10-K (filed 2021-02-11) ↗
FY2017Dec 31, 20172.40+242.9%Form 10-K (filed 2020-02-13) ↗
FY2016Dec 31, 20160.70-82.9%Form 10-K (filed 2019-02-13) ↗
FY2015Dec 31, 20154.10–Form 10-K (filed 2018-02-15) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals SBC capitalized into inventory ($M), annual FY2015–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/sbc-cap

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.